Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Schemas01:42

Schemas

12.3K
A schema is a mental construct consisting of a cluster or collection of related concepts (Bartlett, 1932). There are many different types of schemata, and they all have one thing in common: schemata are a method of organizing information that allows the brain to work more efficiently. When a schema is activated, the brain makes immediate assumptions about the person or object being observed.
12.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adenotonsillectomy for Children with Mild Sleep-Disordered Breathing: Who Benefits?

Sleep·2026
Same author

Progression of mild sleep-disordered breathing in children managed with watchful waiting.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same author

Macrophage-fibroblast signaling networks identified by single-cell RNA sequencing in juvenile systemic sclerosis.

JCI insight·2026
Same author

Autologous stem cell transplantation (ASCT) for Refractory juvenile-onset systemic sclerosis (JSSc).

Annals of the rheumatic diseases·2026
Same author

Are we ready to predict progressive disease in juvenile systemic sclerosis?

Journal of scleroderma and related disorders·2026
Same author

Measuring disease activity in juvenile systemic sclerosis: a multidisciplinary consensus from the Hamburg 2024 symposium.

Expert review of clinical immunology·2026

Related Experiment Video

Updated: Jan 21, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

16.0K

Autoantibodies in Morphea: An Update.

Sangita Khatri1, Kathryn S Torok2, Emily Mirizio2

  • 1Department of Chemistry, Technical University of Denmark, Kongens Lyngby, Denmark.

Frontiers in Immunology
|July 30, 2019
PubMed
Summary

Autoimmune antibodies are key in skin diseases like morphea. New research on autoantibody profiles offers personalized management and diagnostic tools for morphea, improving patient outcomes.

Keywords:
autoantibodydiagnosticsmorpheapersonalized managementskin autoimmunity

More Related Videos

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.9K
Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

709

Related Experiment Videos

Last Updated: Jan 21, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

16.0K
Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.9K
Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

709

Area of Science:

  • Dermatology
  • Immunology
  • Rheumatology

Background:

  • Skin autoimmune conditions, including morphea and systemic sclerosis (SSc), are part of connective tissue diseases.
  • Autoantibodies play a significant role in the pathogenesis of these conditions.
  • Limited detailed studies on autoantibodies hinder effective diagnosis and management of autoimmune skin diseases.

Purpose of the Study:

  • To review the current understanding of autoantibodies in morphea.
  • To highlight recent research on autoantibody detection, role in pathogenesis, and diagnostic potential.
  • To explore novel autoantibody biomarkers for morphea diagnosis and management.

Main Methods:

  • Literature review of recent studies on autoantibodies in morphea.
  • Analysis of autoantibody profiles in relation to disease subtypes, severity, and prognosis.
  • Evaluation of existing and novel autoantibody tests for diagnostic and prognostic value.

Main Results:

  • Autoantibody profiles are increasingly associated with morphea subtypes, disease extent, and relapse risk.
  • Recent studies offer insights into morphea pathogenesis driven by specific autoantibodies.
  • Emerging autoantibody biomarkers show promise for improved diagnosis and personalized treatment.

Conclusions:

  • Autoantibodies are crucial for understanding morphea and developing targeted therapies.
  • Personalized disease management strategies can be enhanced by analyzing autoantibody profiles.
  • Further research into novel autoantibody biomarkers is essential for advancing morphea care.